Incidence and risk factors for methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis.

被引:0
|
作者
Cannon, GW
Cerveny, KC
Finck, BK
Simpson, KM
Strand, V
机构
[1] VA & Univ Utah, Salt Lake City, UT USA
[2] Immunex Corp, Seattle, WA USA
[3] Aventis, Bridgewater, NJ USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S166 / S166
页数:1
相关论文
共 50 条
  • [41] PULMONARY-DISEASE DURING THE TREATMENT OF RHEUMATOID-ARTHRITIS WITH LOW-DOSE PULSE METHOTREXATE
    CARSON, CW
    CANNON, GW
    EGGER, MJ
    WARD, JR
    CLEGG, DO
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1987, 16 (03) : 186 - 195
  • [42] Benefit and risk of methotrexate treatment in rheumatoid arthritis
    Rau, R
    Herborn, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (05) : S83 - S94
  • [43] Risk factors of leflunomide-induced interstitial pneumonifis in patients with rheumatoid arthritis.
    Ju, Ji Hyeon
    Lee, Sang-Il
    Kim, Sung-Il
    Lee, Jee-Soo
    Choi, Jung-Yun
    Kim, Ho-Youn
    Park, Sung-Hwan
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S226 - S226
  • [44] 3 CASES OF PULMONARY DISORDERS DURING TREATMENT OF RHEUMATOID-ARTHRITIS WITH METHOTREXATE
    LEGOFF, P
    FAUQUERT, P
    GUILLERMIT, MN
    REVUE DU RHUMATISME, 1989, 56 (01): : 23 - 25
  • [45] A GENOME-WIDE ASSOCIATION STUDY FOR METHOTREXATE-INDUCED PNEUMONITIS IN RHEUMATOID ARTHRITIS
    Bluett, J.
    Owens, S. -A.
    Massey, J.
    Plant, D.
    Verstappen, S.
    Barton, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 893 - 893
  • [46] Response to methotrexate treatment predicts longterm outcome in patients with rheumatoid arthritis.
    Krause, D
    Gabriel, B
    Herborn, G
    Rau, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S558 - S558
  • [47] Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis
    Hakim, NS
    Kobienia, B
    Benedetti, E
    Bloomer, J
    Payne, WD
    INTERNATIONAL SURGERY, 1998, 83 (03) : 224 - 225
  • [48] BENEFIT OF G-CSF FOR METHOTREXATE-INDUCED NEUTROPENIA IN RHEUMATOID-ARTHRITIS
    ELLMAN, MH
    TELFER, MC
    TURNER, AF
    AMERICAN JOURNAL OF MEDICINE, 1992, 92 (03): : 337 - 338
  • [49] Risk assessment for coronary heart disease in rheumatoid arthritis.
    Erb, N
    Banks, MJ
    Kitas, GD
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S511 - S511
  • [50] Risk factors for high-dose methotrexate-induced nephrotoxicity
    Kawaguchi, Shinichiro
    Fujiwara, Shin-Ichiro
    Murahashi, Rui
    Nakashima, Hirotomo
    Matsuoka, Sae
    Ikeda, Takashi
    Toda, Yumiko
    Ito, Shoko
    Ban, Tetsuaki
    Nagayama, Takashi
    Umino, Kento
    Minakata, Daisuke
    Nakano, Hirofumi
    Yamasaki, Ryoko
    Ashizawa, Masahiro
    Yamamoto, Chihiro
    Hatano, Kaoru
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (01) : 79 - 84